Nicholas Marston

25PUBLICATIONS
349CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Cardiology (incl. cardiovascular diseases)Cardiovascular medicine and haematology not elsewhere classifiedHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jun 08, 2026
Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants.

|May 25, 2026
Lipoprotein(a) Levels, Risk of Cardiovascular Events, and Benefit of Evolocumab: Findings From the VESALIUS-CV Trial.

|May 19, 2026
Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior Myocardial Infarction: Results From the VESALIUS-CV Trial.

|May 18, 2026
Rare coding variant architecture and gene discovery from 130,000 sequenced cases of atrial fibrillation.

|May 11, 2026
Early Versus Late Initiation of Evolocumab and Arterial Aneurysm Events: An Analysis of FOURIER and FOURIER-OLE.

|Mar 30, 2026
Effect of APOC3 Inhibition With Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study.

Nicholas A Marston, Brian A Bergmark, Thomas A Prohaska

Pageof 5

Frequent Collaborators

7 joint publications

Giorgio Melloni

6 joint publications

Marc S Sabatine

6 joint publications

Patrick T Ellinor

5 joint publications

Steven Lubitz